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A. SPECIFIC AIMS
In recent years, the application of magnetic nanoparticles (MNPs) in magnetic fluid hyperthermia
(MFH) has emerged as a viable alternative to radiotherapy, chemotherapy, and surgery for the
treatment of a wide variety of cancerous tumors. The MFH procedure, which requires raising the
temperature of the tumor to 42 – 45o C, has become more prevalent in Europe and Asia as compared
to the rest of the world. Current treatments typically use superparamagnetic iron oxide nanoparticles
(SPIONs) as the magnetic mediator; however, in today’s day and age where efficiency is always a
matter of concern, there is a push for multi-purposed materials. It has been found that a core-shell
nanoparticle system has the capability to generate a larger specific absorption rate (SAR) than standard
nanoparticles [1]. We proposed to develop core-shell magnetic nanoparticles consisting of a
gadolinium-doped iron-oxide core surrounded by an iron-oxide shell which will have properties not
only suited for use as agents in MFH, but also as contrast agents for magnetic resonance imaging (MRI)
The concept of MFH is based on the high heat-sensitivity of malignant neoplastic tissue when
compared to that of normal human cells. For local magnetic fluid hyperthermia, MNPs in a carrier fluid
are delivered to the tumor site via direct injection or targeted to the site through the use of tumor
specific antibodies. Once inside the tumor, the nanoparticles are exposed to an alternating magnetic
field which causes heating of the MNPs due to magnetic relaxation (both Néel and Brownian
mechanisms) as well as hysteretic losses. Such a rise in temperature is enough to kill cancer cells while
leaving healthy tissue unharmed.
Specific Aim #1: Development of a method to synthesize Fe3-xGdxO4/Fe3O4 core/shell
nanoparticles (CSNPs). Our plan is to develop a method by which Fe3-xGdxO4 magnetic nanoparticles
synthesized through a standard coprecipitation method can be coated with an Fe 3O4 shell. The
purpose of this is to develop a core/shell system which has increased magnetic susceptibility due to the
presence of gadolinium but preserves the biocompatibility of Fe3O4-based systems.
Specific Aim #2: Investigation of the structural characteristics of the synthesized
Fe3-xGdxO4/Fe3O4 samples. The Fe3-xGdxO4/Fe3O4 CSNPs will be characterized by X-ray diffraction
(XRD), scanning electron microscopy (SEM) and transmission electron microscopy (TEM) for phase
identification as well as the determination of particle morphology.
Specific Aim #3: Investigation of the magnetic properties of the proposed nanoparticles
through the use of dc- and ac-magnetometry. In order to determine the magnetic properties of the
Fe3-xGdxO4/Fe3O4 CSNPs we will perform temperature-dependent magnetic experiments using the
magnetometers of our collaborators at South Dakota State University and Wayne State University
Specific Aim #4: Investigation of the magnetic heating of an aqueous suspension of the
nanoparticles under an alternating magnetic field. These studies must be performed for a number of
reasons which include the determination of the temperature dependent specific absorption rate (SAR)
of the aqueous Fe3-xGdxO4/Fe3O4 CSNP solution.

Specific Aim #5: Specific Aim # 5: To investigate image contrast properties in magnetic
resonance imaging. Using the Magnetic Resonance Imaging capabilities of our collaborators (Insight
Institute for Neurosurgery and Neuroscience) we plan to perform in vitro investigations of how
aqueous solutions of Fe3-xGdxO4/Fe3O4 CSNP may provide contrast enhancement in functional magnetic
resonance imaging.
B. BACKGROUND AND SIGNIFICANCE
Magnetic hyperthermia has been widely considered as a possible non-invasive treatment for
cancerous solid tumors since its
introduction in 1957 when Gilchrist
et al [2] used 20—100 nm particles
of -Fe2O3 in conjunction with an
alternating magnetic field in the MHz
range to heat various tissue samples.
In broad terms, MFH involves the
dispersion of magnetic nanoparticles
throughout a tumor site and the
exposure of these nanoparticles to a
small (~10-3 T) time-varying magnetic
field in the RF range. The relaxation
of the magnetic nanoparticles into
the field causes dispersion of heat
due to various methods of energy
loss (Néel relaxation, Brownian
relaxation, hysteretic losses, etc.).
This heat is conducted to the nearby
cancerous tissue whereby, if the
temperature can be maintained
above a threshold of 42˚C – 46˚C for
a time of not less than 30 minutes,
the cancer will be destroyed via
necrosis, coagulation and carbonization. The most commonly used materials for this treatment are
mono-metallic oxides such as -Fe2O3 and Fe3O4 (because of their abundance and biocompatibility.
In general, heat production via magnetic materials in alternating magnetic fields arises due to
two general classes of materials: multi-domain ferro(ferri-)magnetic systems and single-domain
superparamagnetic systems. In the former, heat production originates primarily through hysteretic
power losses. For superparamagnetic nanoparticles, heating is accomplished through losses as the
particles’ superspins align with the external field through the Néel mechanism (rotation of the
magnetic moment within a fixed particle) and Brownian motion (physical rotation of the particle
with a fixed moment), the latter of which can contribute to the dissipation of energy by means of
friction [2]. Typically, MFH is accomplished using superparamagnetic iron oxide nanoparticles or
SPIONs (Fe3O4 and -Fe2O3) due to their relative biocompatibility [4 – 8]; however, the specific
absorption rate (SAR) of magnetic liquids based on these materials is limited by their saturation

magnetization. It is our hope that through doping the core with gadolinium we can increase the
saturation magnetization of the particles while preserving their biocompatibility and also provide a
material that can be used not only for MFH but for MRI contrast enhancement as well (many MRI
contrast agents are based on gadolinium chelates [9]).
C. SUMMARY OF EXPERIMENTAL DESIGN AND METHODS
Synthesis of multicore nanoparticles. The synthesis of Fe3-xGdxO4 magnetic nanoparticles
nanoparticles will be accomplished via the wet-chemical coprecipitation of iron and gadolinium
salts. The resulting powders will then be coated with Fe3O4 through various methods outlined in
the literature to determine the best suited method for our purpose [10 – 13].
Structural and morphological characterization. Samples synthesized via the method above will
be analyzed through x-ray diffraction in order to confirm the structural nature and average size of
the nanoparticles. In addition, scanning and transmission electron microscopy will be used to
further investigate the phase and morphology of the samples.
Magnetic characterization. Using a Quantum Design Model 6000 Physical Properties
Measurement system (at Wayne State University) and a Quantum Design Versalab magnetometer
(South Dakota State University), we will investigate the ac- and dc- magnetic properties of the
synthesized samples. We will specifically look at the temperature-dependent properties in order to
determine the Curie temperature of the samples.
Analysis of the heating characteristics. The heating characteristics of each sample will be
measured using Kettering University’s Ambrell EASYHEAT system. Specifically, we are interested in
determining two main points: The specific absorption rate (SAR) of the sample as it heats from
room temperature, and the samples ability to hold a constant temperature in the range of 42—
46˚C while constantly being driven by the ac magnetic field. The SAR is defined to be the power
dissipated by a magnetic material subjected to an alternating magnetic field. For MFH, the SAR is
related to the specific heat of the solvent in which the magnetic nanoparticles are suspended, the
weight fraction of the magnetic element, and the slope of the temperature vs. time curve.
D. POTENTIAL SOURCES OF EXTERNAL FUNDING
The preliminary data obtained from this project presents itself well to solicitation of funds from
both the National Institutes of Health (NIH) and the National Science Foundation (NSF). For
example, the Biomaterials program (BMAT) within the NSF’s Division of Materials Research (DMR)
which supports fundamental research related to (1) biological materials, (2) biometric, bioinspired,
and bioenabled materials, (3) synthetic materials intended for applications in contact with
biological systems, and (4) the processes through which nature produces biological materials (taken
from www.nsf.gov) would be ideal sources of future external funding for this research.

E. BUDGET
We anticipate the following expenses for this project
Budgeted Item
Undergraduate Research Assistantships
Materials and Lab Supplies
Publication Charges
TOTAL

Amount
$4,000.00
$1,500.00
$500.00
$6,000.00
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